HomeCompareIVSS vs JNJ

IVSS vs JNJ: Dividend Comparison 2026

IVSS yields 0.07% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 JNJ wins by $250.00 in total portfolio value· pulled ahead in Year 8
10 years
IVSS
IVSS
● Live price
0.07%
Share price
$25.45
Annual div
$0.02
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$19.8K
Annual income
$7.31
Full IVSS calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — IVSS vs JNJ

📍 JNJ pulled ahead of the other in Year 8

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodIVSSJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, IVSS + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
IVSS pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

IVSS
Annual income on $10K today (after 15% tax)
$6.19/yr
After 10yr DRIP, annual income (after tax)
$6.21/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, JNJ beats the other by $697.40/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of IVSS + JNJ for your $10,000?

IVSS: 50%JNJ: 50%
100% JNJ50/50100% IVSS
Portfolio after 10yr
$19.9K
Annual income
$417.55/yr
Blended yield
2.10%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

IVSS
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

IVSS buys
0
JNJ buys
0
No recent congressional trades found for IVSS or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricIVSSJNJ
Forward yield0.07%3.36%
Annual dividend / share$0.02$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$19.8K$20.0K
Annual income after 10y$7.31$827.78
Total dividends collected$73.00$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: IVSS vs JNJ ($10,000, DRIP)

YearIVSS PortfolioIVSS Income/yrJNJ PortfolioJNJ Income/yrGap
1$10,707$7.28$10,676$355.77+$31.00IVSS
2$11,464$7.28$11,407$389.39+$57.00IVSS
3$12,274$7.29$12,198$426.53+$76.00IVSS
4$13,140$7.29$13,056$467.62+$84.00IVSS
5$14,067$7.30$13,987$513.12+$80.00IVSS
6$15,059$7.30$14,998$563.56+$61.00IVSS
7$16,121$7.30$16,098$619.52+$23.00IVSS
8← crossover$17,257$7.31$17,295$681.69$38.00JNJ
9$18,472$7.31$18,599$750.82$127.00JNJ
10$19,772$7.31$20,022$827.78$250.00JNJ

IVSS vs JNJ: Complete Analysis 2026

IVSSStock

IVSS is actively managed and allocates approximately 80% of net assets to equity securities of US small- to mid-cap companies, defined as those with market capitalizations below $15 billion at purchase. These securities are believed to have potential for superior return. The investment process incorporates an Intrinsic Value Stewardship (IVS) analytical model that assesses factors such as profitability, competition, growth rate, cost of capital, and financing activities. The fund will hold at least 150 positions across various sectors but may take larger positions exceeding 5% in certain holdings or sectors. As a non-diversified fund, it invests in fewer securities than diversified funds. It also invests in convertible securities, preferred stocks, rights, warrants, real estate investment trusts (REITs), and American depositary receipts (ADRs).

Full IVSS Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this IVSS vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

IVSS vs SCHDIVSS vs JEPIIVSS vs OIVSS vs KOIVSS vs MAINIVSS vs ABBVIVSS vs MRKIVSS vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.